Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Ann Oncol

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    April 2017
  1. JAIN P, Aoki E, Keating M, Wierda WG, et al
    Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Ann Oncol. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  2. FRIBERG G, Reese D
    Blinatumomab (Blincyto(R)); lessons learned from the bispecific t-cell engager (BiTE(R)) in acute lymphocytic leukemia (ALL).
    Ann Oncol. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. VOSO MT, Leone G, Piciocchi A, Fianchi L, et al
    in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study.
    Ann Oncol. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  4. INABA H, Pei D, Wolf J, Howard SC, et al
    Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
    Ann Oncol. 2017;28:386-392.
    PubMed     Text format     Abstract available


    January 2017
  5. MATO AR, Hill BT, Lamanna N, Barr PM, et al
    Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.
    Ann Oncol. 2017 Jan 27. pii: mdx031. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. MATO AR, Hill BT, Lamanna N, Barr PM, et al
    Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.
    Ann Oncol. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format    


    November 2016
  7. STAUDER R, Eichhorst B, Hamaker M, Kaplanov K, et al
    Management of Chronic Lymphocytic Leukemia (CLL) in the Elderly: A Position Paper from an International Society of Geriatric Oncology (SIOG) Task Force.
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  8. CICCONI L, Lo-Coco F
    Current Management of Newly Diagnosed Acute Promyelocytic Leukemia.
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


  9. DANG L, Yen K, Attar EC
    IDH mutations in cancer and progress toward development of targeted therapeutics.
    Ann Oncol. 2016;27:599-608.
    PubMed     Text format     Abstract available


  10. MALVEZZI M, Carioli G, Bertuccio P, Rosso T, et al
    European cancer mortality predictions for the year 2016 with focus on leukaemias.
    Ann Oncol. 2016;27:725-31.
    PubMed     Text format     Abstract available


    March 2016
  11. YOON JH, Yhim HY, Kwak JY, Ahn JS, et al
    Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  12. FALCHI L, Vitale C, Keating MJ, Lerner S, et al
    Incidence and Prognostic Impact of Other Cancers in a Population of Long-Term Survivors of Chronic Lymphocytic Leukemia.
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  13. KADIA TM, Ravandi F, Cortes J, Kantarjian H, et al
    New Drugs in Acute Myeloid Leukemia (AML).
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: